Please use this identifier to cite or link to this item:
Type: Journal article
Title: A model of care for familial hypercholesterolaemia: key role for clinical biochemistry
Author: Watts, G.
Sullivan, D.
van Bockxmeer, F.
Poplawski, N.
Hamilton-Craig, I.
Clifton, P.
O'Brien, R.
George, P.
Burnett, J.
Citation: Clinical Biochemist Reviews, 2012; 33(1):25-31
Publisher: Associated Business Publications Pty Ltd
Issue Date: 2012
ISSN: 0159-8090
Organisation: Familial Hypercholesterolaemia Australasia Network
Statement of
Gerald F. Watts, David R. Sullivan, Frank M. van Bockxmeer, Nicola Poplawski, Ian Hamilton-Craig, Peter M. Clifton, Richard C. O’Brien, Peter M. George and John R. Burnett for the Familial Hypercholesterolaemia Australasia Network
Abstract: Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that causes marked elevation in plasma low-density lipoprotein (LDL) cholesterol concentrations and premature coronary heart disease. There are at least 45,000 people with FH in Australia and New Zealand, but most remain unrecognised and those diagnosed remain inadequately treated. To bridge this gap in coronary prevention the FH Australasia Network has developed a model of care for FH. An executive summary of the model of care is presented, with a commentary on its recommendations and the key role of the clinical biochemistry laboratory.
Rights: © 2012 The Australasian Association of Clinical Biochemists Inc.
RMID: 0020122067
Published version:,_2012/?abstract=227
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.